Sideguard®dedicated stent system for the treatment of coronary bifurcation artery lesions

Coronary artery bifurcation disease is considered to be technically challenging since it is one of the most complex lesions owing to great anatomical variability. Recent data suggest the provisional approach of implanting one stent in the main vessel as the default treatment for most bifurcation lesions. However, despite the use of drug-eluting stents and different stenting techniques, coronary bifurcation stenosis continues to be a challenging lesion subset. In particular, management of the so-called ‘true coronary bifurcation lesions’, classified as B2 lesions by the Movahed bifurcation classification (B = bifurcation, 2 = both the main and side branch ostia have disease), requires a longer duration and is associated with a low procedural success rate at both short- and long-term follow-up compared with nonbifurcation lesions, presumably owing to suboptimal results in the side branch. Recently, novel dedicated bifurcation devices have been designed to facilitate the provisional approach, offering easy a...